Walgreens Joins Battle Against Opioid Overdoses

LifeZette reports:

Walgreens announced earlier this week it will begin stocking noloxone, the FDA-approved nasal spray sold under the brand Narcan and used to reverse the effects of an opioid overdose, in all of its pharmacies nationwide.

The pharmacy will also implement the Centers for Disease Control and Prevention (CDC) recommendations to educate patients about Narcan.

“By stocking Narcan in all of our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed,” Rick Gates, Walgreens group vice president of pharmacy, said in a press release on Tuesday. “As a pharmacy we are committed to making Narcan more accessible in the communities we serve.”

View article →